We’ve assembled the most frequently asked questions about Eversense into one place. Got a question that you can’t find the answer to? Contact us.
Eversense® NOW is a mobile App that allows the Eversense® users to share their data and information with friends and family. The Eversense® NOW user will be able to monitor the CGM glucose data of up to 10 Eversense® CGM users.
Note: The Eversense® CGM user has the ability to add/remove friends and family from Eversense NOW access to their data at any time.
Precaution: If you do not allow notifications from the Eversense® NOW App, you will not receive glucose related alerts from Eversense® CGM users.
An internet connection is required to download the app and to receive remote glucose values for display on your Eversense® NOW App.
The Eversense® NOW App lets you join a maximum of 10 Eversense® Circles. If you are invited to join an 11th Circle you will receive an email asking you to remove yourself from an existing Circle before being added to a new one.
The unit of measure is displayed on the My Glucose screen. (You select the unit of measure when the app is first downloaded and you log in the for the first time.) In order to change the unit of measure, you will need to delete/remove the App from your mobile device and download it again.
Removing an Eversense® CGM user from your list means you will no longer be able to remotely monitor their glucose data. To add a user back to your list, contact the Eversense® CGM user to send you a new invitation.
To add a user back to your list, contact the Eversense® CGM user to send you a new invitation.
Note: It can take up to 2 hours for the Eversense® CGM user to see that you are no longer in their Circle on their Eversense® CGM App.
Still have questions?
The Eversense team is dedicated and ready to provide the answers and support you need. Simply click the link below.
The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.
The Eversense® 365 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to one year in people (18 years and older) with diabetes. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are required for calibration one time a week after day 13, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense 365 CGM System is a prescription device; patients should talk to their health care provider to learn more.
For important safety information, see bit.ly/eversensesafety
Eversense, Eversense E3 Continuous Glucose Monitoring, Eversense 365 Continuous Glucose Monitoring, and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, the Ascensia Diabetes Care logo are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.
Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.
PP-SENS-E3-GBL-0060